Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Elicio Therapeutics, Inc. (ELTX) had Operating Cash Flow per Share of $-1.19 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-10.56M |
|
-- |
|
-- |
|
$10.09M |
|
$-10.09M |
|
$-0.47M |
|
$-10.56M |
|
$-10.56M |
|
$-10.56M |
|
$-10.56M |
|
$-10.56M |
|
$-10.56M |
|
$-10.09M |
|
$-9.81M |
|
16.06M |
|
16.06M |
|
$-0.66 |
|
$-0.66 |
|
| Balance Sheet Financials | |
$22.60M |
|
$0.38M |
|
$6.93M |
|
$29.53M |
|
$9.92M |
|
$9.34M |
|
$17.77M |
|
$27.69M |
|
$1.83M |
|
$1.83M |
|
$1.83M |
|
16.26M |
|
| Cash Flow Statement Financials | |
$-19.07M |
|
$0.00M |
|
$22.26M |
|
$19.49M |
|
$22.79M |
|
$3.30M |
|
$1.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.28 |
|
-- |
|
-- |
|
0.84 |
|
5.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-575.85% |
|
-575.85% |
|
-35.77% |
|
-94.54% |
|
$0.11 |
|
$-1.19 |
|
|
Operating Cash Flow per Share |
$-1.19 |